Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Martin Platten & Gerd Fätkenheuer. (2013)
Lersivirine – a new drug for HIV infection therapy. Expert Opinion on Investigational Drugs 22:12, pages 1687-1694.
Read now
Read now
G. Allan, J. Davis, M. Dickins, I. Gardner, T. Jenkins, H. Jones, R. Webster & H. Westgate. (2008) Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of
physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man. Xenobiotica 38:6, pages 620-640.
Read now
Read now
George M Bahr. (2005) Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses. Expert Review of Clinical Immunology 1:4, pages 529-547.
Read now
Read now
RobynM. Hyde, Keith Jensen, Jindrich Kopecek & ArthurD. Broom. (2005) Confocal-microscopy Studies of a Model Oligoribonucleotide HIV Inhibitor. Nucleosides, Nucleotides & Nucleic Acids 24:10-12, pages 1875-1884.
Read now
Read now
Articles from other publishers (40)
Yager & Konan. (2019) Sphingolipids as Potential Therapeutic Targets against Enveloped Human RNA Viruses. Viruses 11:10, pages 912.
Crossref
Crossref
Mattia Mori, Lesia Kovalenko, Sébastien Lyonnais, Danny Antaki, Bruce E. Torbett, Maurizio Botta, Gilles Mirambeau & Yves Mély. 2015. The Future of HIV-1 Therapeutics. The Future of HIV-1 Therapeutics
53
92
.
Jean-Luc Darlix, Hugues de Rocquigny, Olivier Mauffret & Yves Mély. (2014) Retrospective on the all-in-one retroviral nucleocapsid protein. Virus Research 193, pages 2-15.
Crossref
Crossref
Ziying Han, Jianhong Lu, Yuliang Liu, Benjamin Davis, Michael S. Lee, Mark A. Olson, Gordon Ruthel, Bruce D. Freedman, Matthias J. Schnell, Jay E. Wrobel, Allen B. Reitz & Ronald N. Harty. (2014) Small-Molecule Probes Targeting the Viral PPxY-Host Nedd4 Interface Block Egress of a Broad Range of RNA Viruses. Journal of Virology 88:13, pages 7294-7306.
Crossref
Crossref
Guangshun Wang. (2013) Database-Guided Discovery of Potent Peptides to Combat HIV-1 or Superbugs. Pharmaceuticals 6:6, pages 728-758.
Crossref
Crossref
А.М. Андрианов & A.M. Andrianov. (2013) Computer-Aided Search for Novel Anti-Hiv-1 Agents Presenting Peptidomimetics of Neutralizing Antibodies and Evaluation of their Potential Inhibitory Activity by Molecular Modeling. Математическая биология и биоинформатика Mathematical Biology and Bioinformatics 8:1, pages 119-134.
Crossref
Crossref
Sebastian Breuer, Max W. Chang, Jinyun Yuan & Bruce E. Torbett. (2012) Identification of HIV-1 Inhibitors Targeting the Nucleocapsid Protein. Journal of Medicinal Chemistry 55:11, pages 4968-4977.
Crossref
Crossref
Biancamaria Farina, Roberto Fattorusso & Maurizio Pellecchia. (2011) Targeting Zinc Finger Domains with Small Molecules: Solution Structure and Binding Studies of the RanBP2‐Type Zinc Finger of RBM5. ChemBioChem 12:18, pages 2837-2845.
Crossref
Crossref
E. O. Baranova, N. S. Shastina & V. I. Shvets. (2011) Polyanionic inhibitors of HIV adsorption. Russian Journal of Bioorganic Chemistry 37:5, pages 527-542.
Crossref
Crossref
Lisa M Miller Jenkins, David E Ott, Ryo Hayashi, Lori V Coren, Deyun Wang, Qun Xu, Marco L Schito, John K Inman, Daniel H Appella & Ettore Appella. (2010) Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer. Nature Chemical Biology 6:12, pages 887-889.
Crossref
Crossref
Manoli Vourvahis, Michelle Gleave, Angus N. R. Nedderman, Ruth Hyland, Iain Gardner, Martin Howard, Sarah Kempshall, Claire Collins & Robert LaBadie. (2010)
Excretion and Metabolism of Lersivirine (5-{[3,5-Diethyl-1-(2-hydroxyethyl)(3,5-
14
C
2
)-1
H
-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a Next-Generation Non-Nucleoside Reverse Transcriptase Inhibitor, after Administration of [
14
C]Lersivirine to Healthy Volunteers
. Drug Metabolism and Disposition 38:5, pages 789-800.
Crossref
Crossref
Valérie GoldschmidtLisa M Miller Jenkins, Hugues de RocquignyJean-Luc Darlix & Yves Mély. (2010) The nucleocapsid protein of HIV-1 as a promising therapeutic target for antiviral drugs. HIV Therapy 4:2, pages 179-198.
Crossref
Crossref
B. Romani, S. Engelbrecht & R. H. Glashoff. (2009) Functions of Tat: the versatile protein of human immunodeficiency virus type 1. Journal of General Virology 91:1, pages 1-12.
Crossref
Crossref
Fa Liu, Andrew G. Stephen, Abdul A. Waheed, Eric O. Freed, Robert J. Fisher & Terrence R. BurkeJr.Jr.. (2010) Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists. Bioorganic & Medicinal Chemistry Letters 20:1, pages 318-321.
Crossref
Crossref
Mario Sechi, Mauro Carcelli, Dominga Rogolino & Nouri Neamati. 2009. Drug Design of Zinc‐Enzyme Inhibitors. Drug Design of Zinc‐Enzyme Inhibitors
911
936
.
Louise Doyon, Robert Elston & Pierre R. Bonneau. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
477
492
.
Jeffrey D. Fisher, K. Rivet Amico, William A. Fisher & Jennifer J. Harman. (2008) The Information-Motivation-Behavioral Skills model of antiretroviral adherence and its applications. Current HIV/AIDS Reports 5:4, pages 193-203.
Crossref
Crossref
Antonio MastrolorenzoAlfonso MarescaStefano RusconiClaudiu T Supuran. (2008) Update on the development of HIV entry inhibitors. Future HIV Therapy 2:5, pages 479-507.
Crossref
Crossref
Deidra Shuck-Lee, Fei Fei Chen, Ryan Willard, Sharmila Raman, Roger Ptak, Marie-Louise Hammarskjold & David Rekosh. (2008) Heterocyclic Compounds That Inhibit Rev-RRE Function and Human Immunodeficiency Virus Type 1 Replication. Antimicrobial Agents and Chemotherapy 52:9, pages 3169-3179.
Crossref
Crossref
Ruifang Pang, Chunlei Zhang, Dekai Yuan & Ming Yang. (2008) Design and SAR of new substituted purines bearing aryl groups at N9 position as HIV-1 Tat–TAR interaction inhibitors. Bioorganic & Medicinal Chemistry 16:17, pages 8178-8186.
Crossref
Crossref
Fa Liu, Andrew G. Stephen, Abdul A. Waheed, M. Javad Aman, Eric O. Freed, Robert J. Fisher & Terrence R. BurkeJr.Jr.. (2008) SAR by Oxime-Containing Peptide Libraries: Application to Tsg101 Ligand Optimization. ChemBioChem 9:12, pages 2000-2004.
Crossref
Crossref
A.K. Dudani, A. MartyresH. Fliss. (2008)
Short Communication:
Rapid Preparation of Preventive and Therapeutic Whole-Killed Retroviral Vaccines Using the Microbicide Taurine Chloramine
. AIDS Research and Human Retroviruses 24:4, pages 635-642.
Crossref
Crossref
Jim A. Turpin, Marco L. Schito, Lisa M. Miller Jenkins, John K. Inman & Ettore Appella. 2008. HIV-1: Molecular Biology and Pathogenesis. HIV-1: Molecular Biology and Pathogenesis
229
256
.
B. Courcot, D. Firley, B. Fraisse, P. Becker, J.-M. Gillet, P. Pattison, D. Chernyshov, M. Sghaier, F. Zouhiri, D. Desmaële, J. d'Angelo, F. Bonhomme, S. Geiger & N. E. Ghermani. (2007) Crystal and Electronic Structures of Magnesium(II), Copper(II), and Mixed Magnesium(II)−Copper(II) Complexes of the Quinoline Half of Styrylquinoline-Type HIV-1 Integrase Inhibitors. The Journal of Physical Chemistry B 111:21, pages 6042-6050.
Crossref
Crossref
Lian Yi Han, Chan Juan Zheng, Bin Xie, Jia Jia, Xiao Hua Ma, Feng Zhu, Hong Huang Lin, Xin Chen & Yu Zong Chen. (2007) Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness. Drug Discovery Today 12:7-8, pages 304-313.
Crossref
Crossref
Carla J. Berg, Susan E. Michelson & Steven A. Safren. (2007) Behavioral Aspects of HIV Care: Adherence, Depression, Substance Use, and HIV-Transmission Behaviors. Infectious Disease Clinics of North America 21:1, pages 181-200.
Crossref
Crossref
A Robert Neurath, Nathan Strick & Yun-Yao Li. (2006) Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides. BMC Infectious Diseases 6:1.
Crossref
Crossref
Longhu Zhou, Chandar S. Thakur, Ross J. Molinaro, Jayashree M. Paranjape, Rieuwert Hoppes, Kuan-Teh Jeang, Robert H. Silverman & Paul F. Torrence. (2006) Delivery of 2-5A cargo into living cells using the Tat cell penetrating peptide: 2-5A-tat. Bioorganic & Medicinal Chemistry 14:23, pages 7862-7874.
Crossref
Crossref
Masakazu Kamata, Raymond P. Wu, Dong Sung An, Jonathan P. Saxe, Robert Damoiseaux, Michael E. Phelps, Jing Huang & Irvin S.Y. Chen. (2006) Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1 Vpr induced cell death. Biochemical and Biophysical Research Communications 348:3, pages 1101-1106.
Crossref
Crossref
Jeffrey D. Fisher, William A. Fisher, K. Rivet Amico & Jennifer J. Harman. (2006) An information-motivation-behavioral skills model of adherence to antiretroviral therapy.. Health Psychology 25:4, pages 462-473.
Crossref
Crossref
Mario SechiAlessia BacchiMauro CarcelliCarlotta CompariElenia DuceEmilia FisicaroDominga RogolinoPaul GatesMarco DerudasLaith Q. Al-MawsawiNouri Neamati. (2006) From Ligand to Complexes: Inhibition of Human Immunodeficiency Virus Type 1 Integrase by β-Diketo Acid Metal Complexes. Journal of Medicinal Chemistry 49:14, pages 4248-4260.
Crossref
Crossref
C. J. Zheng, L. Y. Han, C. W. Yap, Z. L. Ji, Z. W. Cao & Y. Z. Chen. (2006) Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics. Pharmacological Reviews 58:2, pages 259-279.
Crossref
Crossref
Jinxia Deng, James A. Kelley, Joseph J. Barchi, Tino Sanchez, Raveendra Dayam, Yves Pommier & Nouri Neamati. (2006) Mining the NCI antiviral compounds for HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry 14:11, pages 3785-3792.
Crossref
Crossref
C.A. Menezes de Pádua, C.C. César, P.F. Bonolo, F.A. Acurcio & M.D.C. Guimarães. (2006) High incidence of adverse reactions to initial antiretroviral therapy in Brazil. Brazilian Journal of Medical and Biological Research 39:4, pages 495-505.
Crossref
Crossref
Axel T. Neffe, Matthias Bilang & Bernd Meyer. (2006) Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking. Organic & Biomolecular Chemistry 4:17, pages 3259.
Crossref
Crossref
H John SmithA Denver Russell & Claire Simons. 2005. Smith and Williams' Introduction to the Principles of Drug Design and Action, Fourth Edition. Smith and Williams' Introduction to the Principles of Drug Design and Action, Fourth Edition
557
615
.
Meizi He, Dekai Yuan, Wei Lin, Ruifang Pang, Xiaolin Yu & Ming Yang. (2005) Synthesis and assay of isoquinoline derivatives as HIV-1 Tat–TAR interaction inhibitors. Bioorganic & Medicinal Chemistry Letters 15:17, pages 3978-3981.
Crossref
Crossref
Hugues J.-P. Ryser & Rudolf Flückiger. (2005) Keynote review: Progress in targeting HIV-1 entry. Drug Discovery Today 10:16, pages 1085-1094.
Crossref
Crossref
Kaleab Asres, Ameha Seyoum, Ciddi Veeresham, Franz Bucar & Simon Gibbons. (2005) Naturally derived anti‐HIV agents. Phytotherapy Research 19:7, pages 557-581.
Crossref
Crossref
Xiaolin Yu, Wei Lin, Jingyun Li & Ming Yang. (2004) Synthesis and biological evaluation of novel β-carboline derivatives as Tat–TAR interaction inhibitors. Bioorganic & Medicinal Chemistry Letters 14:12, pages 3127-3130.
Crossref
Crossref